Search results
NASCAR Craftsman Truck Winners - WTOP News
WTOP Washington· 6 hours agoThrough May 12 1. Christian Eckes, 387 (2). 2. Corey Heim, 373 (2). 3. Nicholas Sanchez, 330 (1). 4. Ty Majeski, 326 (0). 5. Taylor Gray, 297 (0). 6. Rajah Caruth, 276 (1). 7. Tyler Ankrum, 275 (0). 8.
Why Uber (UBER) Shares Are Trading Lower Today
StockStory via Yahoo Finance· 5 days agoShares of ride sharing and on demand delivery service Uber (NYSE: UBER) fell 8.9% in the afternoon session after the company reported first quarter...
Earnings Point to Different Routes for Lyft and Uber
PYMNTS.com· 5 days agoUber and Lyft bring to mind the oft-quoted Robert Frost poem. Uber and Lyft’s most recent earnings spotlight the divergent paths the two companies have...
Tech, Media & Telecom Roundup: Market Talk
The Wall Street Journal· 5 days agoUber’s 2Q guidance...the CEO says. Shares slide 6% to $66.21. (dean.seal@wsj.com) 1002 ET – Ad revenues at Fox News were hurt by lower digital traffic...
4 Key Takeaways From Uber's Earnings Call
Investopedia· 6 days agoAfter Uber Technologies (UBER) reported mixed first-quarter results sending shares lower in intraday trading Wednesday, executives joined the company's...
Ross Chastain wins Buckle Up South Carolina 200
The Morning News· 3 days agoRoss Chastain raced to the checkered flag in overtime to win Friday night's Buckle Up South Carolina 200 truck race at Darlington Raceway. Nick Sanchez...
Billionaire Bets: 3 Unexpected Stocks Hedge Funds Are Snapping Up
InvestorPlace· 4 days agoInvesting in hedge funds is not something the average investor can do. Rules are in place to ensure...
Q2 2024 Earnings Forecast for Y-mAbs Therapeutics, Inc. Issued By Wedbush (NASDAQ:YMAB)
ETF DAILY NEWS· 23 hours agoY-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Equities research analysts at Wedbush lowered their Q2 2024 earnings per share (EPS) estimates for shares of Y-mAbs Therapeutics in a ...
Los Angeles Capital Management LLC Buys 52,610 Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)
ETF DAILY NEWS· 7 days agoLos Angeles Capital Management LLC lifted its position in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 17.3% in the 4th quarter, according to its most recent Form 13F filing with ...
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Receives $16.57 Consensus PT from Analysts
ETF DAILY NEWS· 6 days agoY-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat reports ...
